Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

ChrysCapital acquires controlling 70.68% stake in Novartis' India listed unit in first majority pharma investment

India's private equity firm ChrysCapital has completed the acquisition of a controlling 70.68% stake in Novartis India Ltd (NIL) from Swiss pharmaceutical major Novartis AG, marking its first majority-controlled investment in the country's pharmaceutical sector.

The acquisition brings the BSE-listed pharmaceutical company under private equity ownership, with ChrysCapital aiming to build a leading branded generics platform focused on the Indian market.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.